This study was therefore designed to assess the biological role of KITENIN in vitro and in vivo using orthotopic mouse glioma models, as well as to analyze the association between KITENIN expression and clinicopathological findings in patients with glioma, including their survival rates. This evidence concerns the gene VANGL1 and central nervous system cancer.